Coyne Terrance P.
EVP & CFO at RPRX
- Sold, on record
- $73.1M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Nov 17, 2026
- Form 144 notices
- 11
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RPRXRoyalty Pharma plcEVP & CFO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale RPRXRoutineMar 2, 2026 2026
Sold 34,791 shares at $46.78 ($1.6M)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 43.2% of holdings ($3.8M position)45,761 shares left0.5x usual sizeFollows a Form 144Filing
- 2 Form 144 notice RPRXNoticeMar 23, 2026 +21 days
Filed to sell 34,791 shares ($1.6M)
Coyne Terrance P., Officer
10b5-1 plan0.5x usual sizeFiling
- 3 Form 4 sale RPRXRoutineMar 23, 2026 same day
Sold 34,791 shares at $45.53 ($1.6M)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 44.2% of holdings ($3.6M position)43,886 shares left0.5x usual sizeFiling
- 4 Form 4 sale RPRXRoutineApr 1, 2026 +9 days
Sold 34,791 shares at $48.33 ($1.7M)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 51.4% of holdings ($3.3M position)32,916 shares left0.5x usual sizeFiling
- 5 Form 4 sale RPRXRoutineApr 28, 2026 +27 days
Sold 34,791 shares at $49.78 ($1.7M)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 46.4% of holdings ($3.7M position)40,136 shares left0.5x usual sizeFiling
- 6 Form 4 sale RPRXRoutineMay 26, 2026 +28 days
Sold 64,399 shares at $53.98 ($3.5M)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 100% of holdings ($3.5M position)0 shares left0.9x usual sizeFiling
- 7 Form 4 sale RPRXRoutineAug 13, 2026 +79 days
Sold 11,002 shares at $58.68 ($646k)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 100% of holdings ($646k position)0 shares left0.2x usual sizeFiling
- 8 Form 4 sale RPRXUnusualNov 17, 2026 +96 days
Sold 257,122 shares at $68.81 ($17.7M)
Coyne Terrance P., EVP & CFO
10b5-1 planSold 100% of holdings ($17.7M position)0 shares left3.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (33)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Nov 18, 2026 | RPRX | EVP & CFO | Form 4 sale | 257,122 | $17.7M | 100.0% | Unusual | SEC |
| Aug 13, 2026 | Aug 17, 2026 | RPRX | EVP & CFO | Form 4 sale | 11,002 | $646k | 100.0% | Routine | SEC |
| May 26, 2026 | May 28, 2026 | RPRX | EVP & CFO | Form 4 sale | 64,399 | $3.5M | 100.0% | Routine | SEC |
| Apr 28, 2026 | Apr 30, 2026 | RPRX | EVP & CFO | Form 4 sale | 34,791 | $1.7M | 46.4% | Routine | SEC |
| Apr 1, 2026 | Apr 2, 2026 | RPRX | EVP & CFO | Form 4 sale | 34,791 | $1.7M | 51.4% | Routine | SEC |
| Mar 23, 2026 | Mar 25, 2026 | RPRX | EVP & CFO | Form 4 sale | 34,791 | $1.6M | 44.2% | Routine | SEC |
| Mar 23, 2026 | Mar 23, 2026 | RPRX | Officer | Form 144 notice | 34,791 | $1.6M | Notice | SEC | |
| Mar 2, 2026 | Mar 4, 2026 | RPRX | EVP & CFO | Form 4 sale | 34,791 | $1.6M | 43.2% | Routine | SEC |
| Mar 2, 2026 | Mar 2, 2026 | RPRX | Officer | Form 144 notice | 34,791 | $1.7M | Notice | SEC | |
| Feb 23, 2026 | Feb 25, 2026 | RPRX | EVP & CFO | Form 4 sale | 34,791 | $1.6M | 42.2% | Routine | SEC |
| Feb 23, 2026 | Feb 23, 2026 | RPRX | Officer | Form 144 notice | 34,791 | $1.6M | Notice | SEC | |
| Feb 4, 2026 | Feb 4, 2026 | RPRX | EVP & CFO | Form 4 sale | 243,541 | $10.4M | 91.4% | Unusual | SEC |
| Feb 3, 2026 | Feb 3, 2026 | RPRX | Officer | Form 144 notice | 135,117 | $5.8M | Notice | SEC | |
| Feb 2, 2026 | Feb 2, 2026 | RPRX | Officer | Form 144 notice | 108,424 | $4.6M | Notice | SEC | |
| Jan 20, 2026 | Jan 23, 2026 | RPRX | EVP & CFO | Form 4 sale | 69,582 | $2.7M | 65.9% | Routine | SEC |
| Jan 20, 2026 | Jan 20, 2026 | RPRX | Officer | Form 144 notice | 69,582 | $2.7M | Notice | SEC | |
| Jan 2, 2026 | Jan 6, 2026 | RPRX | EVP & CFO | Form 4 sale | 69,582 | $2.7M | 63.6% | Routine | SEC |
| Jan 2, 2026 | Jan 2, 2026 | RPRX | Officer | Form 144 notice | 69,582 | $2.7M | Notice | SEC | |
| Dec 15, 2025 | Dec 17, 2025 | RPRX | EVP & CFO | Form 4 sale | 69,582 | $2.7M | 61.5% | Routine | SEC |
| Dec 15, 2025 | Dec 15, 2025 | RPRX | Officer | Form 144 notice | 69,582 | $2.7M | Notice | SEC | |
| Dec 1, 2025 | Dec 3, 2025 | RPRX | EVP & CFO | Form 4 sale | 69,582 | $2.8M | 59.6% | Routine | SEC |
| Dec 1, 2025 | Dec 1, 2025 | RPRX | Officer | Form 144 notice | 69,582 | $2.8M | Notice | SEC | |
| Nov 24, 2025 | Nov 26, 2025 | RPRX | EVP & CFO | Form 4 sale | 69,582 | $2.7M | 57.7% | Routine | SEC |
| Nov 24, 2025 | Nov 24, 2025 | RPRX | Officer | Form 144 notice | 69,582 | $2.8M | Notice | SEC | |
| Nov 17, 2025 | Nov 19, 2025 | RPRX | EVP & CFO | Form 4 sale | 69,594 | $2.7M | 56.0% | Routine | SEC |
| Nov 17, 2025 | Nov 17, 2025 | RPRX | Officer | Form 144 notice | 69,594 | $2.7M | Notice | SEC | |
| Aug 10, 2023 | Aug 11, 2023 | RPRX | EVP & CFO | Form 4 sale | 75,000 | $2.3M | 8.7% | Routine | SEC |
| Jul 13, 2023 | Jul 14, 2023 | RPRX | EVP & CFO | Form 4 sale | 75,000 | $2.3M | 8.0% | Unusual | SEC |
| Nov 8, 2022 | Nov 10, 2022 | RPRX | EVP & CFO | Form 4 sale | 24,500 | $1.1M | 2.5% | Plan not stated | SEC |
| Nov 2, 2022 | Nov 4, 2022 | RPRX | EVP & CFO | Form 4 sale | 5,500 | $237k | 0.6% | Plan not stated | SEC |
| Aug 1, 2022 | Aug 3, 2022 | RPRX | EVP & CFO | Form 4 sale | 30,000 | $1.3M | 3.0% | Plan not stated | SEC |
| Mar 3, 2021 | Mar 5, 2021 | RPRX | EVP & CFO | Form 4 sale | 100,000 | $4.5M | 33.3% | Unusual | SEC |
| Mar 2, 2021 | Mar 4, 2021 | RPRX | EVP & CFO | Form 4 sale | 100,000 | $4.7M | 25.0% | Unusual | SEC |